Quick Answer
NEUROCRINE BIOSCIENCES INC reported Revenue (ASC 606) of $2.86 billion for fiscal year 2025.
NEUROCRINE BIOSCIENCES INC Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $2.86B | +21.4% |
| 2024 | $2.36B | +24.8% |
| 2023 | $1.89B | +26.8% |
| 2022 | $1.49B | +31.3% |
| 2021 | $1.13B | +8.4% |
| 2020 | $1.05B | +32.7% |
| 2019 | $788.10M | +74.7% |
| 2018 | $451.20M | +179.2% |
| 2017 | $161.63M | +977.5% |
| 2016 | $15.00M | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $794.90M | +27.8% | +15.6% |
| June 30, 2025 | $687.50M | +16.5% | +20.1% |
| March 31, 2025 | $572.60M | +11.1% | -8.0% |
| September 30, 2024 | $622.10M | +24.7% | +5.4% |
| June 30, 2024 | $590.20M | +30.4% | +14.5% |
| March 31, 2024 | $515.30M | +22.6% | +3.3% |
| September 30, 2023 | $498.80M | +28.6% | +10.2% |
| June 30, 2023 | $452.70M | +19.7% | +7.7% |
- NEUROCRINE BIOSCIENCES INC showed an increase of +21.4% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2016–2025 period, NEUROCRINE BIOSCIENCES INC’s revenue (asc 606) has grown by 18970.0% (from $15.00 million to $2.86 billion).
- The most recent figure is from NEUROCRINE BIOSCIENCES INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 11, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: